Factory Supply CAS23111-00-4 NMN NRC Nicotinamide Riboside Chloride on Sale
Nicotinamide Riboside Chloride Quick details
Product Name
|
Nicotinamide Riboside Chloride
|
CAS No.
|
23111-00-4
|
Molecular Formula
|
C11H15N2O5.Cl
|
Molecular Weight
|
290.7002
|
Appearance
|
White powder
|
Assay
|
99.8%min
|
Nicotinamide Riboside Chloride Description :
Nicotinamide Riboside Chloride is the chloride salt form of nicotinamide riboside(NR).NR is a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide(NAD) or NAD+ . Nicotinamide riboside chloride is a crystal form of Nicotinamide riboside (NR) chloride. Nicotinamide riboside chloride increases NAD[+] levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high fat diet-induced metabolic abnormalities. Nicotinamide riboside chloride is used in dietary supplements.
Nicotinamide Riboside Chloride
Uses: Nicotinamide Riboside Chloride is a crystal form of Nicotinamide riboside (NR) chloride termed NIAGEN, generally recognized as safe (GRAS) for use in foods and in dietary supplements. Nicotinamide Riboside Chloride is a source of vitamin B3 (niacin) and enhances oxidative metabolism, protection against high fat diet-induced metabolic abnormalities. Nicotinamide riboside is a newly discovered NAD (NAD+) precursor vitamin.
Detailed Photos
Company Profile
WuHan Vanz Pharm Inc
Wuhan Vanz Pharm Inc., which is specialized in custom synthesis and R&D in APIs and pharmaceutical intermediates, is located in Wuhan, China. We have established long-term cooperation with Shanghai Institute of Organic Chemistry, Wuhan University etc since 2011.
As a special team in organic chemistry and medical chemistry, we also support the technology of R&D on new product. We have strong advantages on the process research and product R&D, pay attention to researching and developing new technology which is self-owned intellectual property right. We are special at developing Drug for the respiratory, antidepressant, antivirus, etc. We have completed R&D of more than 20 APIs and intermediates after the company founded.